1. Market Research
  2. > Cancer
Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • BCC Research
26 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Tumor-specific Antigen Market

  • $ 5500
  • May 2019
  • 140 pages

By 2018, immune response for a range of cancers including kidney, lung, brain (especially glioblastoma), breast, cervical, colorectal, lymphoma, melanoma, pancreatic and prostate cancer were under investigation.

  • Lymphoma
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • World

Blood Cancer Therapeutics: Global Markets to 2023

  • $ 5500
  • December 2018
  • 174 pages

This report forecasts the global market by disease area and discusses market data for leukemia, lymphoma and myeloma.

  • Cancer
  • Leukemia
  • Lymphoma
  • Pathology
  • World

Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

  • $ 5500
  • May 2019
  • 232 pages

Lymphoma, and Myeloma, 2018 Figure ## : New HIV Diagnoses in the United States, by Age Group, 2016 Figure ## : Canadian Healthcare Expenditures, by Source, 2015 and 2040 Figure ## : Rising Aging Population (## Years and Older) in Canada, 1996-2016 Figure ## : Health Spending and Financing,

  • Lymphoma
  • Therapy
  • World

Proteomics: Technologies and Global Markets

  • $ 5500
  • September 2018
  • 235 pages

Lymphomas Ovarian Cancer Prostate Cancer Thyroid Cancer Infectious Diseases Diabetes Neurological Disorders Alzheimer’s Disease Schizophrenia Immune Diseases HLA Typing Autoimmune Disease Cardiovascular Disease Preeclampsia Chapter ## Proteomics Industry Industry Acquisitions Industry Strate

  • Biotechnology
  • Genomics Proteomics And Enabling Technology
  • Lymphoma
  • Proteomics
  • World

Blood Testing: Technologies and Global Markets

  • $ 5500
  • October 2018
  • 224 pages

Lymphoma, 2018 Figure ## : Global Market for Blood Disorder Testing, by Region, 2017-2023 Figure ## : Global Market for Pregnancy Blood Testing, by Region, 2017-2023 Figure ## : Cardiovascular Disease Mortality, by Disease Area, 2017 Figure ## : Global Market for Cardiovascular Blood Testin

  • Diagnostics
  • Lymphoma
  • World

Cancer Cell Analysis, Instruments, Consumables and Reagents

  • $ 5500
  • December 2018
  • 235 pages

Lymphoma, and Myeloma, 2018 Figure ## : Basic Components of a Spectrophotometer Figure ## : Classification of Cell Microarrays Figure ## : Key Application of Quantitative PCR or Real-Time PCR Figure ## : End-User Segmentation Figure ## : Workflow for Gene Expression Figure ## : Prevalence of

  • Cancer
  • Lymphoma
  • Medical Biotechnology
  • Pathology
  • World

Cell Line and Membrane Market

  • $ 5500
  • March 2019
  • 176 pages

Lymphoma, and Myeloma, 2018 Table ## : Global Forensic Testing Market, by Region, Through 2023 Table ## : Current Status of SNP, STR, and DNA Barcode Technologies as Standard Methods for Assessing the Identity of Cell Lines from Different Species Table ## : Global Tissue Engineering Market,

  • Cell Therapy
  • Lymphoma
  • Medical Biotechnology
  • World

Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions

  • $ 5500
  • December 2018
  • 288 pages

Others includes leukemia, lymphoma, multiple myeloma, brain tumor, thyroid cancer and uteral cancer. - Further growth potential and forecast information has been covered for the overall cancer therapeutics market and for segments-cancer types, by region and by country.

  • Cancer
  • Lymphoma
  • Pathology
  • Therapy
  • World

Cell Separation and Characterization in Solid Tumors: Global Markets Through 2023

  • $ 5500
  • December 2018
  • 181 pages

Cancerous cells that form the solid tumor includes sarcomas, carcinomas, lymphomas.

  • Cancer
  • Lymphoma
  • World

Antibody Drugs: Technologies and Global Markets

  • $ 5500
  • September 2017
  • 115 pages

• The global antibody drugs market for lymphoma reached $##. ## billion in 2016.

  • Lymphoma
  • Medical Biotechnology
  • Monoclonal Antibody
  • World
  • Market Shares

Antibody Drug Conjugates: Technologies and Global Markets

  • $ 2500
  • June 2017
  • 132 pages

The report covers three main areas of application, breast cancer, lymphoma and other cancers, including acute myeloid leukemia.

  • Lymphoma
  • Medical Biotechnology
  • World
  • Forecast

Viral Vector and Plasmid DNA: Technologies and Global Markets

  • $ 5500
  • September 2019
  • 133 pages

Some approved gene therapies, like Kymriah for acute lymphoblastic leukemia (ALL) and large B cell lymphoma, have induced market players to research and develop of gene therapy for cancer treatment.

  • Gene Therapy
  • Lymphoma
  • Medical Biotechnology
  • World

Non-opioid Pain Treatment: Global Markets to 2024

  • $ 5500
  • December 2019
  • 165 pages

- Cancer–brain, breast, colorectal, leukemia/ lymphoma, melanoma, prostate, others

  • Analgesic
  • Lymphoma
  • Opioid
  • Therapy
  • World

Cancer Immunology and Oncolytic Virology: Technologies and Global Markets

  • $ 5500
  • May 2017
  • 164 pages

Lymphoma Treatment, by Region, Through 2021 ($ Millions) ## TABLE ## Global Market for Immunotherapy Products for Melanoma Treatment, by Region, Through 2021 ($ Millions) ## TABLE ## Global Market for Immunotherapy Products for Kidney Cancer Treatment, by Region, Through 2021 ($ Million

  • Cancer
  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • World

Protein Analysis: Subfocus on Oncoproteomics

  • $ 5500
  • September 2018
  • 231 pages

Lymphoma Cancer Ovarian Cancer Pancreatic Cancer Prostate Cancer Thyroid Cancer Infectious Diseases Diabetes Neurological Disorders Alzheimer’s Disease Schizophrenia Cardiovascular Diseases Autoimmune Diseases HLA Typing Prenatal Testing Chapter ## Market Breakdown by Type of Service and Ind

  • Drug Development
  • Lymphoma
  • Demand

Global DNA Sequencing: Research, Applied and Clinical Markets

  • $ 5500
  • May 2019
  • 351 pages

The oncology market segment is analyzed by assay type; by sequenced region; and by indication (bladder, brain, breast, colorectal, cancer unknown primary, gastrointestinal stromal tumor, kidney, leukemia/ lymphoma, lung, melanoma, pan-cancer, prostate, thyroid, and other cancer).

  • Biotechnology
  • Genome Sequencing
  • Genomics
  • Genomics Proteomics And Enabling Technology
  • Lymphoma

The Chinese Market for Cancer Intervention

  • $ 5500
  • June 2017
  • 130 pages

Lymphoma Drug Permission in China ## Ovarian, Cervical and Fallopian Tube Drug Permission in China.. ## Melanoma Drug Permission in China. ## Chapter ##: Market Breakdown by Region. ## East China Cancer Intervention Market. ## Middle China Cancer Intervention Market.. ## North Ch

  • Cancer
  • Lymphoma
  • Therapy
  • China
  • Market Shares

Current Research & Developments Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy

  • $ 2750
  • July 2018
  • 273 pages

), a cell-based gene therapy, for the treatment of adult patients with relapsed or refractory large Bcell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell

  • Biopharmaceutical
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • World

Radiotherapy: Technologies and Global Markets

  • $ 5500
  • June 2017
  • 140 pages

Internal radiation therapy applications include: prostate cancer, gynecological cancer, breast cancer, cervical cancer and systemic radiation therapy, hyperthyroidism, bone metastasis, lymphoma and endocrine tumors.

  • Cancer
  • Health Services
  • Lymphoma
  • Specialty Hospital
  • Forecast

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 2750
  • September 2016
  • 504 pages

BY TYPE, 2011-2016 (NO. ) ## FIGURE ## ESTIMATED NEW CASES OF LYMPHOMA IN THE U. S.

  • Blood Disease
  • Cancer
  • Lymphoma
  • Pathology
  • World
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on